Open-Label, Multi-Center, Phase 2 Study of Anti-CCR4 Monoclonal Antibody KW 0761 (mogamulizumab) in Subjects with Previously Treated Peripheral T-cell Lymphoma (PTCL)
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Mogamulizumab (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin
- 31 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Apr 2015 Planned End Date changed from 1 Oct 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 09 Dec 2014 Results ( n=38) presented at the 56th Annual Meeting and Exposition of the American Society of Hematology.